IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

Rhea-AI Summary

IDEXX Laboratories (NASDAQ: IDXX), a leader in veterinary diagnostics, will participate in two upcoming conferences. On February 24 at 9:55 am EST, executives Tina Hunt and Brian McKeon will engage in a virtual fireside chat at the BofA Securities Animal Health Summit. Following that, on March 7 at 11:00 am EST, CEO Jay Mazelsky will present at the 43rd Annual Raymond James Institutional Investors Conference. Live webcasts and archived editions of the presentations will be accessible on the IDEXX website.

WESTBROOK, Maine, Feb. 17, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:

• Thursday, February 24, 9:55 am EST – Tina Hunt, PhD, Executive Vice President and General Manager, Point of Care Diagnostics and Worldwide Operations and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the BofA Securities Animal Health Summit.
• Monday, March 7, 11:00 am EST – Jay Mazelsky, President and Chief Executive Officer, will present at the 43^rd Annual Raymond James Institutional Investors Conference.

Individuals can access the live audio webcasts of the presentations through links on the IDEXX website, www.idexx.com/investors. An archived edition of the presentations will be available via the same link.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful and effective practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs over 10,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Contact:

Investor Relations:
investorrelations@idexx.com
207-556-8155

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/idexx-laboratories-to-present-at-two-upcoming-institutional-investor-conferences-301485236.html

SOURCE IDEXX Laboratories, Inc.

FAQ

When is IDEXX participating in the BofA Securities Animal Health Summit?

IDEXX will participate in the BofA Securities Animal Health Summit on February 24, 2022, at 9:55 am EST.

Who will represent IDEXX at the upcoming conferences?

Tina Hunt and Brian McKeon will represent IDEXX at the BofA Securities Animal Health Summit, while CEO Jay Mazelsky will present at the Raymond James Institutional Investors Conference.

What date will the IDEXX presentation at the Raymond James Conference occur?

The presentation by IDEXX at the Raymond James Institutional Investors Conference is scheduled for March 7, 2022, at 11:00 am EST.

How can I access IDEXX's conference presentations?

Live audio webcasts of IDEXX's conference presentations can be accessed through links available on their official website.

What is IDEXX's stock symbol?

IDEXX Laboratories is listed on NASDAQ with the stock symbol IDXX.